Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CA 19-9 Antikörper

CA 19-9 Reaktivität: Human IHC, FACS, IF, ISt Wirt: Maus Monoclonal SPM588 unconjugated
Produktnummer ABIN6941361
  • Target Alle CA 19-9 Antikörper anzeigen
    CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))
    Reaktivität
    • 34
    • 1
    • 1
    Human
    Wirt
    • 21
    • 15
    Maus
    Klonalität
    • 32
    • 3
    Monoklonal
    Konjugat
    • 19
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CA 19-9 Antikörper ist unkonjugiert
    Applikation
    • 19
    • 14
    • 14
    • 13
    • 9
    • 5
    • 5
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunofluorescence (IF), Immunostaining (ISt)
    Spezifität
    CA19-9, a carbohydrate epitope expressed on a high MW (400 kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens. In normal tissues, sialyl Lewisa antigen is present in ductal epithelium of the breast, kidney, salivary gland, and sweat glands. Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas, including adenocarcinomas of the stomach, intestine, and pancreas. Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery. When used serially, CA19-9 can predict recurrence of disease prior to radiographic or clinical findings. This MAb is superb for staining of formalin-fixed, paraffin-embedded tissues.
    Immunogen
    Precipitin lines obtained after immuno-diffusion using MAb 116-NS-19-9 and mucins isolated from an ovarian cyst of a Lewis A+B- patient (0Le).
    Klon
    SPM588
    Isotyp
    IgM kappa
    Top Product
    Discover our top product CA 19-9 Primärantikörper
  • Applikationshinweise

    Positive Control: Stomach.

    Known Application: Flow Cytometry (0.5-1 μg/million cells), Immunofluorescence (0.5-1 μg/mL), Immunohistochemistry (Formalin-fixed) (0.5-1.0 μg/mL for 30 minutes at RT)(No special pretreatment is required for the immunohistochemical staining of formalin-fixed, paraffin-embedded tissues.)Optimal dilution for a specific application should be determined.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    200 μg/mL
    Buffer
    10 mM PBS with 0.05 % BSA & 0.05 % azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-80 °C
    Informationen zur Lagerung
    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
    Haltbarkeit
    24 months
  • Target
    CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))
    Andere Bezeichnung
    CA19-9/Sialyl Lewisa (GI Tumor Marker) (CA 19-9 Produkte)
    Molekulargewicht
    >400kDa
Sie sind hier:
Kundenservice